Recent advances in systemic therapy for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common and lethal malignant tumors in the world. Therapeutic options for advanced HCC are limited. Systemic treatment, especially with conventional cytotoxic drugs, is usually ineffective. For more than a decade, sorafenib has been the only systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huajun, Zhang, Wuyang, Jiang, Longying, Chen, Yongheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744248/
https://www.ncbi.nlm.nih.gov/pubmed/35000616
http://dx.doi.org/10.1186/s40364-021-00350-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744248/
https://www.ncbi.nlm.nih.gov/pubmed/35000616
http://dx.doi.org/10.1186/s40364-021-00350-4

Ejemplares similares